FDA panel takes up tough questions on J&J COVID-19 boosters

WASHINGTON (AP) — U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson’s single-shot COVID-19 vaccine and when — and whether using a competi

Related Keywords

United States ,Washington ,Americans ,Johnson ,Pfizer ,Hayley Gans Of Stanford University ,Shore University Hospital In Bay ,Science Department ,Drug Administration ,Associated Press ,South Shore University Hospital ,Bay Shore ,Hayley Gans ,Johan Van ,Associated Press Health ,Howard Hughes Medical Institute ,